Primary Site >> Colorectal Cancer
Gene >> IL2
| 1. | |||||||||||
| Journal: | J Natl Cancer Inst. 1985 Jul;75(1):67-75. | ||||||||||
| Title: | Lymphokine-activated killer (LAK) cell phenomenon. IV. Lysis by LAK cell clones of fresh human tumor cells from autologous and multiple allogeneic tumors. | ||||||||||
| Author: | Rayner, A A|Grimm, E A|Lotze, M T|Wilson, D J|Rosenberg, S A | ||||||||||
| PMID: | 2989604 | ||||||||||
| 2. | |||||||||||
| Journal: | Cancer. 1985 Mar 15;55(6):1327-33. | ||||||||||
| Title: | Lymphokine-activated killer (LAK) cells. Analysis of factors relevant to the immunotherapy of human cancer. | ||||||||||
| Author: | Rayner, A A|Grimm, E A|Lotze, M T|Chu, E W|Rosenberg, S A | ||||||||||
| PMID: | 3871657 | ||||||||||
| 3. | |||||||||||
| Journal: | J Natl Cancer Inst. 1985 Apr;74(4):893-8. | ||||||||||
| Title: | Interleukin generation in experimental colon cancer of rats: effects of tumor growth and tumor therapy. | ||||||||||
| Author: | Ravikumar, T|Rodrick, M|Steele, G Jr|Marrazo, J|O'Dwyer, P|Dodson, T|King, V | ||||||||||
| PMID: | 3872959 | ||||||||||
| 4. | |||||||||||
| Journal: | N Engl J Med. 1985 Dec 5;313(23):1485-92. | ||||||||||
| Title: | Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. | ||||||||||
| Author: | Rosenberg, S A|Lotze, M T|Muul, L M|Leitman, S|Chang, A E|Ettinghausen, S E|Matory, Y L|Skibber, J M|Shiloni, E|Vetto, J T | ||||||||||
| PMID: | 3903508 | ||||||||||
| 5. | |||||||||||
| Journal: | J Immunol. 1985 Feb;134(2):802-7. | ||||||||||
| Title: | Leu-11+ lymphocytes with natural killer (NK) activity are precursors of recombinant interleukin 2 (rIL 2)-induced activated killer (AK) cells. | ||||||||||
| Author: | Itoh, K|Tilden, A B|Kumagai, K|Balch, C M | ||||||||||
| PMID: | 3917475 | ||||||||||
| 6. | |||||||||||
| Journal: | J Immunol. 1985 Sep;135(3):1731-8. | ||||||||||
| Title: | Lymphokine-activated and natural killer cell activity in human intestinal mucosa. | ||||||||||
| Author: | Hogan, P G|Hapel, A J|Doe, W F | ||||||||||
| PMID: | 3926882 | ||||||||||
| 7. | |||||||||||
| Journal: | Gan To Kagaku Ryoho. 1986 Dec;13(12):3419-26. | ||||||||||
| Title: | [In vitro enhancement of cytotoxicity of human peripheral blood lymphocytes with recombinant interleukin 2 and an interferon mixture (alpha + beta + gamma) against human colon carcinoma cell line SW1116]. | ||||||||||
| Author: | Kimoto, Y | ||||||||||
| PMID: | 3098183 | ||||||||||
| 8. | |||||||||||
| Journal: | Cancer. 1986 Feb 1;57(3):656-62. | ||||||||||
| Title: | Production of and response to interleukin-2 in peripheral blood lymphocytes of cancer patients. | ||||||||||
| Author: | Wanebo, H J|Pace, R|Hargett, S|Katz, D|Sando, J | ||||||||||
| PMID: | 3484660 | ||||||||||
| 9. | |||||||||||
| Journal: | Surgery. 1986 Aug;100(2):262-72. | ||||||||||
| Title: | A new approach to the therapy of cancer based on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2. | ||||||||||
| Author: | Rosenberg, S A|Lotze, M T|Muul, L M|Leitman, S|Chang, A E|Vetto, J T|Seipp, C A|Simpson, C | ||||||||||
| PMID: | 3526604 | ||||||||||
| 10. | |||||||||||
| Journal: | J Immunol. 1987 May 15;138(10):3566-72. | ||||||||||
| Title: | Analysis of effector cells in human antibody-dependent cellular cytotoxicity with murine monoclonal antibodies. | ||||||||||
| Author: | Ortaldo, J R|Woodhouse, C|Morgan, A C|Herberman, R B|Cheresh, D A|Reisfeld, R | ||||||||||
| PMID: | 2437198 | ||||||||||
| 11. | |||||||||||
| Journal: | J Immunol. 1987 Apr 1;138(7):2161-8. | ||||||||||
| Title: | Characterization of an immunosuppressive factor derived from colon cancer cells. | ||||||||||
| Author: | Ebert, E C|Roberts, A I|O'Connell, S M|Robertson, F M|Nagase, H | ||||||||||
| PMID: | 3104453 | ||||||||||
| 12. | |||||||||||
| Journal: | Acta Haematol. 1987;78 Suppl 1:75-6. | ||||||||||
| Title: | Therapy of cancer using the adoptive transfer of activated killer cells and interleukin-2. | ||||||||||
| Author: | Topalian, S L|Rosenberg, S A | ||||||||||
| PMID: | 3124451 | ||||||||||
| 13. | |||||||||||
| Journal: | Dis Colon Rectum. 1987 Jul;30(7):503-7. | ||||||||||
| Title: | Reduced incidence of hepatic metastases by perioperative treatment with recombinant human interleukin-2. | ||||||||||
| Author: | Weese, J L|Emoto, S E|Sondel, P M | ||||||||||
| PMID: | 3496196 | ||||||||||
| 14. | |||||||||||
| Journal: | Int J Cancer. 1987 Jul 15;40(1):104-7. | ||||||||||
| Title: | Human tumor cell lines with pleiotropic drug resistance are efficiently killed by interleukin-2 activated killer cells and by activated monocytes. | ||||||||||
| Author: | Allavena, P|Grandi, M|D'Incalci, M|Geri, O|Giuliani, F C|Mantovani, A | ||||||||||
| PMID: | 3496283 | ||||||||||
| 15. | |||||||||||
| Journal: | Cancer Res. 1987 Aug 1;47(15):4208-12. | ||||||||||
| Title: | Severe hypovitaminosis C occurring as the result of adoptive immunotherapy with high-dose interleukin 2 and lymphokine-activated killer cells. | ||||||||||
| Author: | Marcus, S L|Dutcher, J P|Paietta, E|Ciobanu, N|Strauman, J|Wiernik, P H|Hutner, S H|Frank, O|Baker, H | ||||||||||
| PMID: | 3496958 | ||||||||||
| 16. | |||||||||||
| Journal: | J Natl Cancer Inst. 1987 Nov;79(5):1067-75. | ||||||||||
| Title: | In vivo antitumor activity of tumor-infiltrating lymphocytes expanded in recombinant interleukin-2. | ||||||||||
| Author: | Spiess, P J|Yang, J C|Rosenberg, S A | ||||||||||
| PMID: | 3500355 | ||||||||||
| 17. | |||||||||||
| Journal: | Cancer Res. 1988 Jan 15;48(2):260-4. | ||||||||||
| Title: | In vivo antitumor activity of multiple injections of recombinant interleukin 2, alone and in combination with three different types of recombinant interferon, on various syngeneic murine tumors. | ||||||||||
| Author: | Iigo, M|Sakurai, M|Tamura, T|Saijo, N|Hoshi, A | ||||||||||
| PMID: | 2446744 | ||||||||||
| 18. | |||||||||||
| Journal: | J Immunol. 1988 Nov 15;141(10):3492-7. | ||||||||||
| Title: | An 80 to 85 kilodalton human phosphoglycoprotein associated with cell activation. | ||||||||||
| Author: | Omary, M B|Kelleher, D|Kagnoff, M F | ||||||||||
| PMID: | 3183379 | ||||||||||
| 19. | |||||||||||
| Journal: | Cancer Res. 1988 May 1;48(9):2372-6. | ||||||||||
| Title: | Susceptibility of chemoresistant murine and human tumor cells to lysis by interleukin 2-activated lymphocytes. | ||||||||||
| Author: | Gambacorti-Passerini, C|Rivoltini, L|Supino, R|Rodolfo, M|Radrizzani, M|Fossati, G|Parmiani, G | ||||||||||
| PMID: | 3258541 | ||||||||||
| 20. | |||||||||||
| Journal: | J Clin Oncol. 1988 May;6(5):839-53. | ||||||||||
| Title: | Immunotherapy of patients with advanced cancer using tumor-infiltrating lymphocytes and recombinant interleukin-2: a pilot study. | ||||||||||
| Author: | Topalian, S L|Solomon, D|Avis, F P|Chang, A E|Freerksen, D L|Linehan, W M|Lotze, M T|Robertson, C N|Seipp, C A|Simon, P | ||||||||||
| PMID: | 3259261 | ||||||||||
| 21. | |||||||||||
| Journal: | Gan To Kagaku Ryoho. 1988 Apr;15(4 Pt 2-1):788-96. | ||||||||||
| Title: | [Adoptive immunotherapy of malignant disease using LAK cells]. | ||||||||||
| Author: | Kimoto, Y|Taguchi, T | ||||||||||
| PMID: | 3260466 | ||||||||||
| 22. | |||||||||||
| Journal: | Cancer Res. 1988 Aug 1;48(15):4409-16. | ||||||||||
| Title: | Laboratory correlates of adoptive immunotherapy with recombinant interleukin-2 and lymphokine-activated killer cells in humans. | ||||||||||
| Author: | Boldt, D H|Mills, B J|Gemlo, B T|Holden, H|Mier, J|Paietta, E|McMannis, J D|Escobedo, L V|Sniecinski, I|Rayner, A A | ||||||||||
| PMID: | 3260537 | ||||||||||
| 23. | |||||||||||
| Journal: | J Clin Invest. 1988 Oct;82(4):1466-70. | ||||||||||
| Title: | Interleukin 1 promotes tumor cell adhesion to cultured human endothelial cells. | ||||||||||
| Author: | Dejana, E|Bertocchi, F|Bortolami, M C|Regonesi, A|Tonta, A|Breviario, F|Giavazzi, R | ||||||||||
| PMID: | 3262629 | ||||||||||
| 24. | |||||||||||
| Journal: | Ann Intern Med. 1988 Dec 15;109(12):953-8. | ||||||||||
| Title: | The hemodynamic effects of treatment with interleukin-2 and lymphokine-activated killer cells. | ||||||||||
| Author: | Gaynor, E R|Vitek, L|Sticklin, L|Creekmore, S P|Ferraro, M E|Thomas, J X Jr|Fisher, S G|Fisher, R I | ||||||||||
| PMID: | 3264128 | ||||||||||
| 25. | |||||||||||
| Journal: | J Surg Res. 1988 Apr;44(4):445-54. | ||||||||||
| Title: | Lymphokine-activated killer (LAK) cells from human intestinal mucosa: cytotoxic activity against tumor cell lines and modified self but not autologous and allogeneic colon cancer cells. | ||||||||||
| Author: | Trudel, J L|Youngman, K R|West, G A|Fazio, V W|Fiocchi, C | ||||||||||
| PMID: | 3361887 | ||||||||||
| 26. | |||||||||||
| Journal: | Cancer Immunol Immunother. 1989;28(1):43-53. | ||||||||||
| Title: | Inhibition of lymphokine-activated killer cell generation by cultured tumor cell lines in vitro. | ||||||||||
| Author: | Guillou, P J|Sedman, P C|Ramsden, C W | ||||||||||
| PMID: | 2462468 | ||||||||||
| 27. | |||||||||||
| Journal: | Nihon Geka Gakkai Zasshi. 1989 Sep;90(9):1451-4. | ||||||||||
| Title: | [Adoptive immunotherapy of advanced cancer patients with immune RNA-sensitized lymphocytes]. | ||||||||||
| Author: | Fukushima, M|Takashima, K|Tachibana, M|Tsushima, T|Ogura, Y|Hasegawa, Y|Koie, H | ||||||||||
| PMID: | 2479817 | ||||||||||
| 28. | |||||||||||
| Journal: | Cancer Immunol Immunother. 1989;30(1):65-70. | ||||||||||
| Title: | Cytostatic and cytotoxic activity of lymphokine-activated killer cell supernatants. | ||||||||||
| Author: | Hersh, E M|Scuderi, P|Grimes, W J|Chong, A|Brailey, J L|Gschwind, C R|Salmon, S E | ||||||||||
| PMID: | 2480843 | ||||||||||
| 29. | |||||||||||
| Journal: | Jpn J Cancer Res. 1989 Sep;80(9):895-903. | ||||||||||
| Title: | Combination therapy of colon carcinoma 26 in mice with recombinant human interleukin-2 and interferon-alpha A/D: occurrence of large granular cells in the tumor. | ||||||||||
| Author: | Sakura, Y|Ootsu, K|Shino, A | ||||||||||
| PMID: | 2513305 | ||||||||||
| 30. | |||||||||||
| Journal: | J Clin Oncol. 1989 Apr;7(4):486-98. | ||||||||||
| Title: | Interleukin-2 and lymphokine-activated killer cell therapy of solid tumors: analysis of toxicity and management guidelines. | ||||||||||
| Author: | Margolin, K A|Rayner, A A|Hawkins, M J|Atkins, M B|Dutcher, J P|Fisher, R I|Weiss, G R|Doroshow, J H|Jaffe, H S|Roper, M | ||||||||||
| PMID: | 2647914 | ||||||||||
| 31. | |||||||||||
| Journal: | Int J Cancer. 1989 Apr 15;43(4):598-607. | ||||||||||
| Title: | A monoclonal antibody (D612) with selective reactivity for malignant and normal gastro-intestinal epithelium. | ||||||||||
| Author: | Muraro, R|Nuti, M|Natali, P G|Bigotti, A|Simpson, J F|Primus, F J|Colcher, D|Greiner, J W|Schlom, J | ||||||||||
| PMID: | 2649441 | ||||||||||
| 32. | |||||||||||
| Journal: | J Clin Oncol. 1989 Jul;7(7):869-78. | ||||||||||
| Title: | Recombinant interleukin-2 by continuous infusion and adoptive transfer of recombinant interleukin-2-activated cells in patients with advanced cancer. | ||||||||||
| Author: | Paciucci, P A|Holland, J F|Glidewell, O|Odchimar, R | ||||||||||
| PMID: | 2661733 | ||||||||||
| 33. | |||||||||||
| Journal: | Cancer Treat Rev. 1989 Jun;16 Suppl A:163-7. | ||||||||||
| Title: | A phase-II trial of recombinant interleukin-2 and 5-FU chemotherapy in patients with metastatic colorectal carcinoma. | ||||||||||
| Author: | Hamblin, T J|Inzani, V|Sadullah, S|Stevenson, F K|Williamson, P|van der Plas, J|Palmer, P|Franks, C R | ||||||||||
| PMID: | 2670212 | ||||||||||
| 34. | |||||||||||
| Journal: | Ann Surg. 1989 Oct;210(4):474-84; discussion 484-5. | ||||||||||
| Title: | Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients. | ||||||||||
| Author: | Rosenberg, S A|Lotze, M T|Yang, J C|Aebersold, P M|Linehan, W M|Seipp, C A|White, D E | ||||||||||
| PMID: | 2679456 | ||||||||||
| 35. | |||||||||||
| Journal: | Cancer Res. 1989 Jan 1;49(1):235-40. | ||||||||||
| Title: | Influence of schedule of interleukin 2 administration on therapy with interleukin 2 and lymphokine activated killer cells. | ||||||||||
| Author: | Thompson, J A|Lee, D J|Lindgren, C G|Benz, L A|Collins, C|Shuman, W P|Levitt, D|Fefer, A | ||||||||||
| PMID: | 2783243 | ||||||||||
| 36. | |||||||||||
| Journal: | J Clin Oncol. 1989 Jan;7(1):75-80. | ||||||||||
| Title: | Phase II trial of outpatient interleukin-2 in malignant lymphoma, chronic lymphocytic leukemia, and selected solid tumors. | ||||||||||
| Author: | Allison, M A|Jones, S E|McGuffey, P | ||||||||||
| PMID: | 2783339 | ||||||||||
| 37. | |||||||||||
| Journal: | Clin Immunol Immunopathol. 1989 Jan;50(1 Pt 1):72-81. | ||||||||||
| Title: | Characterization of activated lymphocytes in colon cancer. | ||||||||||
| Author: | Ebert, E C|Brolin, R E|Roberts, A I | ||||||||||
| PMID: | 2783402 | ||||||||||
| 38. | |||||||||||
| Journal: | J Clin Oncol. 1989 Feb;7(2):276-84. | ||||||||||
| Title: | A phase I clinical trial of recombinant interleukin-2 by periodic 24-hour intravenous infusions. | ||||||||||
| Author: | Creekmore, S P|Harris, J E|Ellis, T M|Braun, D P|Cohen, I I|Bhoopalam, N|Jassak, P F|Cahill, M A|Canzoneri, C L|Fisher, R I | ||||||||||
| PMID: | 2783732 | ||||||||||
| 39. | |||||||||||
| Journal: | Cancer Immunol Immunother. 1989;28(2):136-42. | ||||||||||
| Title: | Influence of the donors' clinical status on in vitro and in vivo tumor-cytotoxic activation of interleukin-2-exposed lymphocytes and their circulation in different organs. | ||||||||||
| Author: | Rodolfo, M|Salvi, C|Parmiani, G | ||||||||||
| PMID: | 2783888 | ||||||||||
| 40. | |||||||||||
| Journal: | Cancer Res. 1989 May 15;49(10):2773-6. | ||||||||||
| Title: | Murine monoclonal IgG3 to human colorectal tumor-associated antigens: enhancement of antibody-dependent cell-mediated cytotoxicity by interleukin 2. | ||||||||||
| Author: | Morgan, A C Jr|Sullivan, W|Graves, S|Woodhouse, C S | ||||||||||
| PMID: | 2785437 | ||||||||||
| 41. | |||||||||||
| Journal: | J Biol Response Mod. 1989 Apr;8(2):122-39. | ||||||||||
| Title: | Phase I trial of recombinant interleukin-2 and recombinant beta-interferon in refractory neoplastic diseases. | ||||||||||
| Author: | Paolozzi, F|Zamkoff, K|Doyle, M|Konrad, M|Bradley, E C|Rudolph, A|Newman, N|Gullo, J|Scalzo, A|Poiesz, B | ||||||||||
| PMID: | 2786553 | ||||||||||
| 42. | |||||||||||
| Journal: | Cancer. 1989 Jul 15;64(2):396-403. | ||||||||||
| Title: | Adriamycin-induced resistance to natural killer (NK)-mediated cytotoxicity. | ||||||||||
| Author: | Wood, W J Jr|Lotzova, E | ||||||||||
| PMID: | 2786743 | ||||||||||
| 43. | |||||||||||
| Journal: | Eur J Cancer Clin Oncol. 1989 Jun;25(6):965-72. | ||||||||||
| Title: | Tolerance and effectiveness of recombinant interleukin-2 (r-met Hu IL-2 [ala-125]) and lymphokine-activated killer cells in patients with metastatic solid tumors. | ||||||||||
| Author: | Stahel, R A|Sculier, J P|Jost, L M|Delforge, A|Bron, D|Gmur, J|Oelz, O|Sauter, C|Stryckmans, P|Klastersky, J | ||||||||||
| PMID: | 2787749 | ||||||||||
| 44. | |||||||||||
| Journal: | J Biol Response Mod. 1989 Oct;8(5):468-78. | ||||||||||
| Title: | Treatment of patients with advanced cancer using multiple long-term cultured lymphokine-activated killer (LAK) cell infusions and recombinant human interleukin-2. | ||||||||||
| Author: | Mittelman, A|Savona, S|Gafney, E|Penichet, K O|Lin, B Y|Levitt, D|Ahmed, T|Arlin, Z A|Baskind, P|Needleman, D | ||||||||||
| PMID: | 2795092 | ||||||||||
| 45. | |||||||||||
| Journal: | Cancer. 1989 Dec 1;64(11):2238-42. | ||||||||||
| Title: | Lymphokine-activated killer cell induction in tumor-infiltrating leukocytes from colon cancer patients. | ||||||||||
| Author: | Staren, E D|Economou, S G|Harris, J E|Braun, D P | ||||||||||
| PMID: | 2804913 | ||||||||||
| 46. | |||||||||||
| Journal: | Cancer Res. 1990 Oct 1;50(19):6158-61. | ||||||||||
| Title: | Selective immunosuppressive action of a factor produced by colon cancer cells. | ||||||||||
| Author: | Ebert, E C|Roberts, A I|Devereux, D|Nagase, H | ||||||||||
| PMID: | 1698119 | ||||||||||
| 47. | |||||||||||
| Journal: | Onkologie. 1990 Dec;13(6):416-22. | ||||||||||
| Title: | The clinical significance of interleukin-2. | ||||||||||
| Author: | Bergmann, L | ||||||||||
| PMID: | 2092277 | ||||||||||
| 48. | |||||||||||
| Journal: | Scand J Immunol. 1990 Mar;31(3):275-82. | ||||||||||
| Title: | Swainsonine, an inhibitor of glycoprotein processing, enhances cytotoxicity of large granular lymphocytes. | ||||||||||
| Author: | Yagita, M|Saksela, E | ||||||||||
| PMID: | 2108487 | ||||||||||
| 49. | |||||||||||
| Journal: | Int J Cancer. 1990 Dec 15;46(6):1021-8. | ||||||||||
| Title: | Lymphokine-activated killer cell cytotoxicity against human colon carcinomas enhanced by monoclonal antibody D612. | ||||||||||
| Author: | Pendurthi, T K|Parker, R|Schlom, J|Primus, F J | ||||||||||
| PMID: | 2123477 | ||||||||||
| 50. | |||||||||||
| Journal: | Cell. 1990 Feb 9;60(3):397-403. | ||||||||||
| Title: | Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response. | ||||||||||
| Author: | Fearon, E R|Pardoll, D M|Itaya, T|Golumbek, P|Levitsky, H I|Simons, J W|Karasuyama, H|Vogelstein, B|Frost, P | ||||||||||
| PMID: | 2137372 | ||||||||||
| 51. | |||||||||||
| Journal: | Cancer Immunol Immunother. 1990;31(4):231-5. | ||||||||||
| Title: | Granulocyte-monocyte colony-stimulating-factor augments the interleukin-2-induced cytotoxic activity of human lymphocytes in the absence and presence of mouse or chimeric monoclonal antibodies (mAb 17-1A). | ||||||||||
| Author: | Masucci, G|Ragnhammar, P|Wersall, P|Mellstedt, H | ||||||||||
| PMID: | 2199042 | ||||||||||
| 52. | |||||||||||
| Journal: | J Clin Oncol. 1990 Oct;8(10):1618-29. | ||||||||||
| Title: | Intraperitoneal lymphokine-activated killer-cell and interleukin-2 therapy for malignancies limited to the peritoneal cavity. | ||||||||||
| Author: | Steis, R G|Urba, W J|VanderMolen, L A|Bookman, M A|Smith, J W 2nd|Clark, J W|Miller, R L|Crum, E D|Beckner, S K|McKnight, J E | ||||||||||
| PMID: | 2213099 | ||||||||||
| 53. | |||||||||||
| Journal: | J Clin Oncol. 1990 Oct;8(10):1657-63. | ||||||||||
| Title: | Phase I study of interleukin-2 and interferon alfa-2a as outpatient therapy for patients with advanced malignancy. | ||||||||||
| Author: | Hirsh, M|Lipton, A|Harvey, H|Givant, E|Hopper, K|Jones, G|Zeffren, J|Levitt, D | ||||||||||
| PMID: | 2213102 | ||||||||||
| 54. | |||||||||||
| Journal: | Br J Cancer. 1990 Dec;62(6):1042-6. | ||||||||||
| Title: | Paradoxical effects of 5-FU/folinic acid on lymphokine-activated killer (LAK) cell induction in patients with colorectal cancer. | ||||||||||
| Author: | Onodera, H|Somers, S S|Guillou, P J | ||||||||||
| PMID: | 2257211 | ||||||||||
| 55. | |||||||||||
| Journal: | J Pharmacobiodyn. 1990 Jul;13(7):426-31. | ||||||||||
| Title: | Suppression of tumor cell growth and mitogen response by aporphine alkaloids, dicentrine, glaucine, corydine, and apomorphine. | ||||||||||
| Author: | Kondo, Y|Imai, Y|Hojo, H|Endo, T|Nozoe, S | ||||||||||
| PMID: | 2290126 | ||||||||||
| 56. | |||||||||||
| Journal: | Gastroenterology. 1990 Feb;98(2):259-68. | ||||||||||
| Title: | Tumor-infiltrating lymphocytes from human colon carcinomas. Functional and phenotypic characteristics after long-term culture in recombinant interleukin 2. | ||||||||||
| Author: | Yoo, Y K|Heo, D S|Hata, K|Van Thiel, D H|Whiteside, T L | ||||||||||
| PMID: | 2295382 | ||||||||||
| 57. | |||||||||||
| Journal: | Cancer Immunol Immunother. 1990;31(1):28-36. | ||||||||||
| Title: | Adoptive immunotherapy of a mouse colon carcinoma with recombinant interleukin-2 alone or combined with lymphokine-activated killer cells or tumor-immune lymphocytes. Survival benefit of adjuvant post-surgical treatments and comparison with experimental m | ||||||||||
| Author: | Rodolfo, M|Salvi, C|Bassi, C|Parmiani, G | ||||||||||
| PMID: | 2306753 | ||||||||||
| 58. | |||||||||||
| Journal: | Mol Biother. 1990 Mar;2(1):18-26. | ||||||||||
| Title: | Low-dose subcutaneous recombinant interleukin-2 in advanced human malignancy: a phase II outpatient study. | ||||||||||
| Author: | Atzpodien, J|Korfer, A|Evers, P|Franks, C R|Knuver-Hopf, J|Lopez-Hanninen, E|Fischer, M|Mohr, H|Dallmann, I|Hadam, M | ||||||||||
| PMID: | 2334534 | ||||||||||
| 59. | |||||||||||
| Journal: | Cancer Res. 1990 Jun 15;50(12):3681-90. | ||||||||||
| Title: | Evaluation of tetrazolium-based semiautomatic colorimetric assay for measurement of human antitumor cytotoxicity. | ||||||||||
| Author: | Heo, D S|Park, J G|Hata, K|Day, R|Herberman, R B|Whiteside, T L | ||||||||||
| PMID: | 2340518 | ||||||||||
| 60. | |||||||||||
| Journal: | Gastroenterol Jpn. 1990 Apr;25(2):180-5. | ||||||||||
| Title: | Time course of changes in phenotypes of cultured tumor-infiltrating lymphocytes isolated from human colorectal cancer. | ||||||||||
| Author: | Shimazaki, M|Ninomiya, M|Muto, Y|Saito, K|Moriwaki, H | ||||||||||
| PMID: | 2347471 | ||||||||||
| 61. | |||||||||||
| Journal: | Cancer Immunol Immunother. 1990;31(6):349-57. | ||||||||||
| Title: | Chimeric B72.3 mouse/human (IgG1) antibody directs the lysis of tumor cells by lymphokine-activated killer cells. | ||||||||||
| Author: | Primus, F J|Pendurthi, T K|Hutzell, P|Kashmiri, S|Slavin, D C|Callahan, R|Schlom, J | ||||||||||
| PMID: | 2386980 | ||||||||||
| 62. | |||||||||||
| Journal: | J Surg Res. 1991 Apr;50(4):410-5. | ||||||||||
| Title: | Natural killer cell stimulatory factor (NKSF) augments natural killer cell and antibody-dependent tumoricidal response against colon carcinoma cell lines. | ||||||||||
| Author: | Lieberman, M D|Sigal, R K|Williams, N N 2nd|Daly, J M | ||||||||||
| PMID: | 1673486 | ||||||||||
| 63. | |||||||||||
| Journal: | Int J Cancer. 1991 Mar 12;47(5):746-54. | ||||||||||
| Title: | The high lysability by LAK cells of colon-carcinoma cells resistant to doxorubicin is associated with a high expression of ICAM-1, LFA-3, NCA and a less-differentiated phenotype. | ||||||||||
| Author: | Rivoltini, L|Cattoretti, G|Arienti, F|Mastroianni, A|Melani, C|Colombo, M P|Parmiani, G | ||||||||||
| PMID: | 1706327 | ||||||||||
| 64. | |||||||||||
| Journal: | J Immunol. 1991 Jun 15;146(12):4421-6. | ||||||||||
| Title: | Molecular and functional analysis of human natural killer cell-associated neural cell adhesion molecule (N-CAM/CD56). | ||||||||||
| Author: | Lanier, L L|Chang, C|Azuma, M|Ruitenberg, J J|Hemperly, J J|Phillips, J H | ||||||||||
| PMID: | 1710251 | ||||||||||
| 65. | |||||||||||
| Journal: | J Immunother (1991). 1991 Dec;10(6):412-7. | ||||||||||
| Title: | Cell surface expression of ICAM-1 (CD54) and LFA-3 (CD58), two adhesion molecules, is up-regulated on bone marrow leukemic blasts after in vivo administration of high-dose recombinant interleukin-2. | ||||||||||
| Author: | Olive, D|Lopez, M|Blaise, D|Viens, P|Stoppa, A M|Brandely, M|Mawas, C|Mannoni, P|Maraninchi, D | ||||||||||
| PMID: | 1722705 | ||||||||||
| 66. | |||||||||||
| Journal: | Int Immunol. 1991 Oct;3(10):959-64. | ||||||||||
| Title: | Lymphokine-activated killer-cell-mediated killing of WiDr colon carcinoma cells is inhibited by K562 erythroleukemia cells. | ||||||||||
| Author: | Dullens, H F|Wind, J C|Maas, R A|Bernsen, M R|Vulto, I M|Rademakers, L H|Den Otter, W | ||||||||||
| PMID: | 1756146 | ||||||||||
| 67. | |||||||||||
| Journal: | Cancer Immunol Immunother. 1991;34(1):53-62. | ||||||||||
| Title: | Therapeutic use of a long-term cytotoxic T cell line recognizing a common tumour-associated antigen: the pattern of in vitro reactivity predicts the in vivo effect on different tumours. | ||||||||||
| Author: | Rodolfo, M|Bassi, C|Salvi, C|Parmiani, G | ||||||||||
| PMID: | 1760812 | ||||||||||
| 68. | |||||||||||
| Journal: | Nat Immun Cell Growth Regul. 1991;10(6):308-19. | ||||||||||
| Title: | Adjuvant adoptive immunotherapy with IL2 and lymphocytes from tumor-bearing mice: in vitro tumor-stimulated lymphocytes are more effective than LAK cells. | ||||||||||
| Author: | Rodolfo, M|Salvi, C|Bassi, C|Rovetta, G|Melani, C|Colombo, M P|Parmiani, G | ||||||||||
| PMID: | 1787836 | ||||||||||
| 69. | |||||||||||
| Journal: | J Immunother (1991). 1991 Oct;10(5):297-306. | ||||||||||
| Title: | Immunological effects of levamisole in vitro. | ||||||||||
| Author: | Schiller, J H|Lindstrom, M|Witt, P L|Hank, J A|Mahvi, D|Wagner, R J|Sondel, P|Borden, E C | ||||||||||
| PMID: | 1790137 | ||||||||||
| 70. | |||||||||||
| Journal: | J Immunother (1991). 1991 Oct;10(5):371-5. | ||||||||||
| Title: | Relapse after response to interleukin-2-based immunotherapy: patterns of progression and response to retreatment. | ||||||||||
| Author: | Sherry, R M|Rosenberg, S A|Yang, J C | ||||||||||
| PMID: | 1790145 | ||||||||||
| 71. | |||||||||||
| Journal: | Eur J Cancer. 1991;27(2):149-54. | ||||||||||
| Title: | Factors influencing the establishment of tumour-infiltrating lymphocyte cultures from human breast carcinoma and colon carcinoma tissue. | ||||||||||
| Author: | Crannage, K E|Rogers, K|Jacob, G|Stoddard, C J|Thomas, W E|Potter, C W|Rees, R C | ||||||||||
| PMID: | 1827279 | ||||||||||
| 72. | |||||||||||
| Journal: | Am J Clin Oncol. 1991 Aug;14(4):341-8. | ||||||||||
| Title: | Immunotherapy with IL2 by constant infusion and weekly doxorubicin. | ||||||||||
| Author: | Paciucci, P A|Bekesi, J G|Ryder, J S|Odchimar, R|Chahinian, P A|Holland, J F | ||||||||||
| PMID: | 1830717 | ||||||||||
| 73. | |||||||||||
| Journal: | Cancer Immunol Immunother. 1991;34(1):9-16. | ||||||||||
| Title: | Human recombinant interleukin-6 enhances antibody-dependent cellular cytotoxicity of human tumor cells mediated by human peripheral blood mononuclear cells. | ||||||||||
| Author: | Tsang, K Y|Finch, M D|Primus, F J|Schlom, J | ||||||||||
| PMID: | 1836975 | ||||||||||
| 74. | |||||||||||
| Journal: | Cancer Immunol Immunother. 1991;32(5):280-8. | ||||||||||
| Title: | Effects of cytokines on in vitro growth of tumor-infiltrating lymphocytes obtained from human primary and metastatic liver tumors. | ||||||||||
| Author: | Shimizu, Y|Iwatsuki, S|Herberman, R B|Whiteside, T L | ||||||||||
| PMID: | 1847844 | ||||||||||
| 75. | |||||||||||
| Journal: | Cancer Immunol Immunother. 1991;33(5):346-9. | ||||||||||
| Title: | Treatment of chemically induced autochthonous rat mammary and colorectal carcinomas with interleukin-2. | ||||||||||
| Author: | Berger, M R|Salas, M|Garzon, F|Petru, E|Schwulera, U|Schmahl, D | ||||||||||
| PMID: | 1868493 | ||||||||||
| 76. | |||||||||||
| Journal: | Semin Surg Oncol. 1991 Jul-Aug;7(4):183-91. | ||||||||||
| Title: | Immunotherapy of cancer with lymphokines and lymphokine-activated killer cells. | ||||||||||
| Author: | Yarbro, J W | ||||||||||
| PMID: | 1925249 | ||||||||||
| 77. | |||||||||||
| Journal: | Br J Cancer. 1991 Nov;64(5):956-8. | ||||||||||
| Title: | Decrease in cholesterol levels during the immunotherapy of cancer with interleukin-2. | ||||||||||
| Author: | Lissoni, P|Brivio, F|Pittalis, S|Perego, M S|Ardizzoia, A|Mauri, O|Barni, S|Crispino, S|Tancini, G | ||||||||||
| PMID: | 1931624 | ||||||||||
| 78. | |||||||||||
| Journal: | J Gastroenterol Hepatol. 1991 Sep-Oct;6(5):455-60. | ||||||||||
| Title: | Intestinal lymphokine-activated killer cells in inflammatory bowel disease. | ||||||||||
| Author: | Hogan, P G|Gibson, P R|Hapel, A J|Doe, W F | ||||||||||
| PMID: | 1932665 | ||||||||||
| 79. | |||||||||||
| Journal: | Cancer Res. 1991 Dec 1;51(23 Pt 1):6312-6. | ||||||||||
| Title: | Biological monitoring of low-dose interleukin 2 in humans: soluble interleukin 2 receptors, cytokines, and cell surface phenotypes. | ||||||||||
| Author: | Hanninen, E L|Korfer, A|Hadam, M|Schneekloth, C|Dallmann, I|Menzel, T|Kirchner, H|Poliwoda, H|Atzpodien, J | ||||||||||
| PMID: | 1933892 | ||||||||||
| 80. | |||||||||||
| Journal: | Nihon Geka Gakkai Zasshi. 1991 Sep;92(9):1229-33. | ||||||||||
| Title: | [Splenic or hepatic arterial injections of interleukin-2 with chemotherapeutic agents for hepatic metastases]. | ||||||||||
| Author: | Okuno, K|Onishi, H|Nakajima, I|Shirayama, Y|Hirohata, T|Ozaki, M|Yasutomi, M | ||||||||||
| PMID: | 1944193 | ||||||||||
| 81. | |||||||||||
| Journal: | Am J Clin Nutr. 1991 Dec;54(6 Suppl):1292S-1297S. | ||||||||||
| Title: | Hypovitaminosis C in patients treated with high-dose interleukin 2 and lymphokine-activated killer cells. | ||||||||||
| Author: | Marcus, S L|Petrylak, D P|Dutcher, J P|Paietta, E|Ciobanu, N|Strauman, J|Wiernik, P H|Hutner, S H|Frank, O|Baker, H | ||||||||||
| PMID: | 1962585 | ||||||||||
| 82. | |||||||||||
| Journal: | Cancer Res. 1991 Feb 1;51(3):926-34. | ||||||||||
| Title: | Characterization of the colorectal carcinoma-associated antigen defined by monoclonal antibody D612. | ||||||||||
| Author: | Fernsten, P D|Primus, F J|Greiner, J W|Simpson, J F|Schlom, J | ||||||||||
| PMID: | 1988133 | ||||||||||
| 83. | |||||||||||
| Journal: | Clin Pharm. 1991 Feb;10(2):110-28. | ||||||||||
| Title: | |||||||||||